Signaling studies revealed that DOCK2 (Dedicator of cytokinesis 2), ERK1/2, JNK and Akt signals mediate CXCL13 invasive and proliferative responses in prostate cancer cells. This evidence concerns the gene CXCL13 and prostate carcinoma.